DiaSorin S.p.A.(DSRLF)

Research Snapshot

DiaSorin S.p.A. (DSRLF) is a Healthcare stock with a market cap of $3.32B and listed on OTC. The stock last traded around $74.25 and down 31.0% across the available one-year price window (Jun 27, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of +0.8%, EPS growth of -20.5%, a dividend yield of 1.9%. What stands out right now is revenue +0.8%, EPS -20.5%, free cash flow -14.2% with operating margin 26.5% and ROIC 11.8%. The dividend is present but secondary, with a yield around 1.9%. Valuation is more restrained than many high-expectation growth names at P/E 18.0 and price/sales 2.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines DSRLF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.